CALIFORNIA BANCORP ANNOUNCES FIRST CASH DIVIDEND GlobeNewswire December 08, 2025 San Diego, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — California Bancorp (the “Company”) (Nasdaq: BCAL), the holding company for California Bank of Commerce, N.A. (the “Bank”), announces that its Board of Directors has approved the Company's first quarterly cash dividend. This strategic decision reflects the […]

SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management GlobeNewswire December 08, 2025 MIAMI, Dec. 08, 2025 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune

Neurona Therapeutics Presents New Long-Term Clinical Data from NRTX-1001 Cell Therapy Trials at 2025 Annual Meeting of the American Epilepsy Society GlobeNewswire December 08, 2025 – NON-MTS & BILATERAL MTLE: First data reported from non-MTS and bilateral MTLE subjects demonstrate robust seizure reduction – LOW DOSE COHORT: 89% median reduction in disabling seizures for unilateral

4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 08, 2025 EMERYVILLE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today

Gabelli Launches Keeley Dividend ETF (KDVD) Harnessing 16+ years of dividend-strategy expertise in an actively managed ETF GlobeNewswire December 08, 2025 GREENWICH, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) — Gabelli Funds, LLC (“Gabelli”) today announced the launch of the Keeley Dividend ETF (“KDVD”) on the NYSE. KDVD is an actively managed ETF that seeks to

Brazil Potash Achieved Major 2025 Milestones, Positions for Construction Advancement in 2026 GlobeNewswire December 08, 2025 Signed Contracts to Sell ~91% of Production, Strengthened Leadership Team, Advanced Site Preparation and Community Partnerships 2026 Focus on Construction Financing, Completing Advanced Engineering, Indigenous Impact Benefit Agreement, and Strategic Partnerships CEO Matt Simpson to outline company progress and

How Fenstermaker Uses Handheld Lidar to Map Schools for 911 Safety and Response Fenstermaker, NEI, and Lafayette Parish 911 use the TrueView GO to Create Digital School Maps that Give First Responders a Head Start When Seconds Count GlobeNewswire December 08, 2025 Huntsville, AL, Dec. 08, 2025 (GLOBE NEWSWIRE) — GeoCue announces the premiere of

Westwood Holdings Group, Inc. Recognized in Pensions & Investments' Best Places to Work in Money Management GlobeNewswire December 08, 2025 NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — Westwood Holdings Group, Inc. was recognized in the 2025 Best Places to Work in Money Management awards announced by Pensions & Investments today. Presented by Pensions &

Tessera Therapeutics Showcases New Preclinical Data Demonstrating Progress of In Vivo Programs for Sickle Cell Disease and T Cell Therapies at the 67th American Society of Hematology Annual Meeting GlobeNewswire December 08, 2025 Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of

RESTEM Announces First-Patient-Dosed in the Phase 1/2a Study of Restem-L in Facioscapulohumeral Muscular Dystrophy GlobeNewswire December 08, 2025 âˆ' First patient with facioscapulohumeral muscular dystrophy (FSHD) dosed with Restem-L umbilical lining modified progenitor cells (UMPCs) âˆ' The Phase 1/2a study will evaluate the safety and preliminary efficacy of Restem-L in patients with FSHD âˆ' Clinical